Standex director sells about $14K in stock

SXI director Thomas E. Chorman sold a small block of shares under a pre-arranged Rule 10b5-1 trading plan and continues to hold over twelve thousand shares.

Rhea-AI Filing Summary

STANDEX INTERNATIONAL CORP (SXI) director Thomas E. Chorman reported selling 50 shares of common stock on September 1, 2026 in an open-market or private transaction at $284.89 per share, for about $14,244.

The sale was made pursuant to an existing Rule 10b5-1 trading plan dated November 6, 2025, and Chorman now holds 12,316 shares directly.

Insider Trade Summary 10b5-1

Net Seller: 50 shares

Net Sell 1 txn

Insider CHORMAN THOMAS E

Role Director

Sold 50 shs ($14K)

Type	Security	Shares	Price	Value
Sale	Common Stock F1	50	$284.89	$14K

Holdings After Transaction: Common Stock — 12,316 shares (Direct)

Footnotes (1)

1. F1. Sale of stock pursuant to existing 10b5-1 trading plan dated November 6, 2025.

Key Figures

Shares sold: 50 shares Sale price per share: $284.89 per share Approximate transaction value: $14,244.50 +2 more

5 metrics

Shares sold 50 shares Common stock sale on September 1, 2026

Sale price per share $284.89 per share Common stock sale on September 1, 2026

Approximate transaction value $14,244.50 50 shares sold at $284.89 per share

Shares held after transaction 12,316 shares Direct holdings of Thomas E. Chorman after the sale

Net shares sold in filing 50 shares Net buy/sell activity across all reported transactions

Key Terms

Rule 10b5-1 trading plan, open market or private transaction

2 terms

Rule 10b5-1 trading plan regulatory

"Sale of stock pursuant to existing 10b5-1 trading plan dated November 6, 2025"

A Rule 10b5-1 trading plan is a pre-arranged schedule that allows company insiders to buy or sell stock at specific times, even if they have inside information. It helps prevent accusations of unfair trading by making these transactions look planned and transparent, rather than sneaky or illegal.

open market or private transaction market

"Sale in open market or private transaction"

FAQ

What insider transaction did SXI director Thomas E. Chorman report?

Thomas E. Chorman reported a sale of 50 SXI common shares on September 1, 2026, described as a sale in an open market or private transaction at $284.89 per share.

How many STANDEX INTERNATIONAL CORP (SXI) shares did Chorman sell and at what price?

Chorman sold 50 SXI shares at a price of $284.89 per share, for a total value of roughly $14,244, as reported in the Form 4.

How many SXI shares does Thomas E. Chorman hold after this transaction?

After the reported sale, Thomas E. Chorman directly holds 12,316 shares of STANDEX INTERNATIONAL CORP common stock, according to the Form 4 disclosure.

Was the SXI insider sale made under a Rule 10b5-1 plan?

Yes. The filing states the sale was a sale of stock pursuant to an existing 10b5-1 trading plan dated November 6, 2025, and the Rule 10b5-1 checkbox is affirmed.

What is the overall direction of insider activity in this SXI Form 4?

The Form 4 reports a net sale of 50 shares, with one sale transaction and no purchases or derivative exercises disclosed for this reporting period.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 09/03/2026 - 10:21 AM Accepted by SEC EDGAR 09/03/2026 - 10:20 AM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

X

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

CHORMAN THOMAS E

(Last) (First) (Middle)

STANDEX INTERNATIONAL CORPORATION

23 KEEWAYDIN DRIVE, SUITE 300

(Street)

SALEM NEW HAMPSHIRE 03079

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
STANDEX INTERNATIONAL CORP/DE/ [ SXI ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
09/01/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	09/01/2026		S(1)		50	D	$284.89	12,316	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Sale of stock pursuant to existing 10b5-1 trading plan dated November 6, 2025.

	/s/ Kristine L. Ouimet	09/03/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)